+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas Device Systems - Global Market Trajectory & Analytics

  • ID: 5139630
  • Report
  • April 2021
  • Region: Global
  • 115 Pages
  • Global Industry Analysts, Inc
Global Artificial Pancreas Device Systems Market to Reach $949.2 Million by 2027

Amid the COVID-19 crisis, the global market for Artificial Pancreas Device Systems estimated at US$264.7 Million in the year 2020, is projected to reach a revised size of US$949.2 Million by 2027, growing at a CAGR of 20% over the analysis period 2020-2027. Threshold suspended device system, one of the segments analyzed in the report, is projected to record a 19.4% CAGR and reach US$780.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTR System segment is readjusted to a revised 20.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $78.5 Million, While China is Forecast to Grow at 19.3% CAGR

The Artificial Pancreas Device Systems market in the U.S. is estimated at US$78.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$163.4 Million by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

CTT System Segment to Record 24.4% CAGR

In the global CTT System segment, USA, Canada, Japan, China and Europe will drive the 24.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$20.9 Million in the year 2020 will reach a projected size of US$95.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.1 Million by the year 2027.

Select Competitors (Total 47 Featured):
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Pancreum, Inc.
  • Tandem Diabetes Care, Inc.
  • TypeZero Technologies LLC
Frequently Asked Questions about the Global Market for Artificial Pancreas Device Systems

What is the estimated value of the Global Market for Artificial Pancreas Device Systems?

The Global Market for Artificial Pancreas Device Systems was estimated to be valued at $264.7 Million in 2020.

What is the growth rate of the Global Market for Artificial Pancreas Device Systems?

The growth rate of the Global Market for Artificial Pancreas Device Systems is 20.0%, with an estimated value of $949.2 Million by 2027.

What is the forecasted size of the Global Market for Artificial Pancreas Device Systems?

The Global Market for Artificial Pancreas Device Systems is estimated to be worth $949.2 Million by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGY
II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Threshold suspended device system by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Threshold suspended device system by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for CTR System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for CTR System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for CTT System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for CTT System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • Table 9: USA Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 10: USA 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 11: Canada Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 12: Canada 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 13: Japan Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: Japan 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 15: China Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 16: China 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 17: Europe Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: Europe 7-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 19: Europe Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Europe 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 21: France Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: France 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 23: Germany Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: Germany 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 25: Italy Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Italy 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 27: UK Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: UK 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 29: Rest of Europe Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Rest of Europe 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 31: Asia-Pacific Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Asia-Pacific 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027
  • Table 33: Rest of World Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold suspended device system, CTR System and CTT System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Rest of World 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold suspended device system, CTR System and CTT System for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 47
Note: Product cover images may vary from those shown